and our daily headlines will be delivered to your inbox each morning.
.. he wasn't certain, though, how much he'd be able to work before then.
.
treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk.
.
china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214).
.
three other countries � spain, czech republic, and slovakia � had also been warned by the eu, but devised sufficient air management plans within the requested time frame.
.
.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.